Interstitial cystitis and systemic autoimmune diseases

Nature Clinical Practice Urology

Volumn 4, Issue 9, 2007, Pages 484-491

  van de Merwe, Joop P ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; EPITHELIAL MEMBRANE ANTIGEN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MUSCARINIC M3 RECEPTOR; RANTES; TUMOR NECROSIS FACTOR;

ANTIGEN BINDING; AUTOIMMUNE DISEASE; CHOLINERGIC ACTIVITY; DETRUSOR MUSCLE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; HUMAN; IMMUNOREACTIVITY; INTERSTITIAL CYSTITIS; MAST CELL; MYASTHENIA GRAVIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS;

AUTOIMMUNE DISEASES; CYSTITIS, INTERSTITIAL; FEMALE; HUMANS; MALE; RECEPTOR, MUSCARINIC M3; SEX FACTORS; SJOGREN'S SYNDROME;

EID: 34548477194     PISSN: 17434270     EISSN: 17434289     Source Type: Journal    
DOI: 10.1038/ncpuro0874     Document Type: Review

References (68)

1. Nordling J et al. (2004) Primary evaluation of patients suspected of having interstitial cystitis (IC). Eur Urol 45: 662-669
2. Erickson DR et al. (2001) Nonbladder related symptoms in patients with interstitial cystitis. J Urol 166: 557-561
3. Ito T et al. (2000) Interstitial cystitis in Japan. BJU Int 86: 634-637
4. Curhan GC et al. (1999) Epidemiology of interstitial cystitis: A population based study. J Urol 161: 549-552
5. Rosenberg MT and Hazzard M (2005) Prevalence of interstitial cystitis symptoms in women: A population based study in the primary care office. J Unol 174: 2231-2234
6. Leppilahti M et al. (2005) Prevalence of clinically confirmed interstitial cystitis in women: A population based study in Finland. J Urol 174: 581-583
7. Temmi C et al. (2006) Prevalence and correlates for interstitial cystitis symptoms in women participating in a health screening project. Eur Urol 51: 803-808
8. Propert KJ et al. (2000) A prospective study of interstitial cystitis: Results of longitudinal followup of the interstitial cystitis data base cohort. The Interstitial Cystitis Data Base Study Group. J Urol 163: 1434-1439
9. Jones CA et al. (1994) Prevalence of interstitial cystitis in the United States. J Urol 151: 423A
10. Abrams P et al. (2002) The standardisation of terminology of lower urinary tract function: Report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 21: 167-178
11. Oberpenning F et al. (2002) Interstitial cystitis: An update. Curr Opin Urol 12: 321-332
12. Van de Merwe JP et al. (1993) Sjögren's syndrome in patients with interstitial cystitis. J Rheumatol 20: 962-966
13. Van de Merwe JP (2003) Sjögren's syndrome in patients with interstitial cystitis. Preliminary results in 100 patients. Int J Urol 10 (Suppl): S69
14. Alagiri M et al. (1997) Interstitial cystitis: Unexplained associations with other chronic disease and pain syndromes. Urology 49 (SA Suppl): S52-S57
15. Yamada T (2003) Significance of complications of allergic diseases in young patients with interstitial cystitis. Int J Urol (10 Suppl): S56-S58
16. Peeker R et al. (2003) Intercurrent autoimmune conditions in classic and non-ulcer interstitial cystitis. Scand J Urol Nephrol 37: 60-63
17. Ochs RL and Tan EM (1997) Autoimmunity and interstitial cystitis. In Interstitial Cystitis, 47-52 (Ed. Sant GR) Philadelphia: Lippincott-Raven
18. Ochs RL et al. (1994) Autoantibodies in interstitial cystitis. J Urol 151: 587-592
19. Keay S et al. (1997) Urine autoantibodies in interstitial cystitis. J Urol 157: 1083-1087
20. Danchenko N et al. (2006) Epidemiology of systemic lupus erythematosus: A comparison of worldwide disease burden. Lupus 15: 308-318
21. Alarçon-Segovia D et al. (1984) Involvement of the urinary bladder in systemic lupus erythrmatosus. A pathologic study. J Rheumatol 11: 208-210
22. Grennan DM et al. (1977) Sjögren's syndrome in SLE: Part 2. An examination of the clinical significance of Sjögren's syndrome by comparison of its frequency in typical and atypical forms of SLE, overlap syndromes and scleroderma. N Z Med J 86: 376-379
23. Andanopoulos AP et al. (1990) Sjögren's syndrome in systemic lupus erythematosus. J Rheumatol 17: 201-204
24. Gilboe IM et al. (2001) Sicca symptoms and secondary Sjögren's syndrome in systemic lupus erythematosus: Comparison with rheumatoid arthritis and correlation with disease variables. Ann Rheum Dis 60: 1103-1109
25. Drosos AA et al. (1990) Subacute cutaneous lupus erythematosus in Greece. A clinical, serological and genetic study. Ann Med Interne (Paris) 141: 421-424
26. Chen MY et al. (2004) Is there an ethnic difference in the prevalence of lupus cystitis? A report of six cases. Lupus 13 263-269
27. Vercammen M et al. (2007) Diagnostic accuracy of the FIDIS multiplex fluorescent microsphere immunodetection system for anti-extractable nuclear antigen (ENA) antibodies in connective tissue diseases. Clin Chem Lab Med 45: 505-612
28. Sauerland U et al. (2005) Clinical utility of the anti-CCP assay: experiences with 700 patients. Ann NY Acad Sci 1050: 314-318
29. Van Noord C et al. (2005) Diagnostic value of anti-cyclic citrullinated peptide antibodies to detect rheumatoid arthritis in patients with Sjögren's syndrome. Ann Rheum Dis 64: 160-162
30. Cohen MG and Webb J (1987) Concurrence of rheumatoid arthritis and systemic lupus erythematosus: Report of 11 cases. Ann Rheum Dis 46: 853-858
31. Alarçon-Segovia D et al. (2005) Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases in 1,177 lupus patients from the GLADEL cohort. Arthritis Rheum 52: 1138-1147
32. Andonopoulos AP et al. (1987) Secondary Sjogren's syndrome in rheumatoid arthritis. J Rheumatol 14: 1098-1103
33. Lee KL et al. (2006) Lower urinary tract symptoms in female patients with rheumatoid arthritis. Scand J Rheumatol 35: 96-101
34. Fox RI et al. (1984) Primary Sjögren syndrome: Clinical and immunopathologic features. Semin Arthritis Rheum 14: 77-105
35. Asherson RA et al. (1992) Antiphosp olipid antibodies and HLA associations in primary Sjögren's syndrome. Ann Rheum Dis 51 495-498
36. Yasuda S et al. (2004) Abacterial prostatitis and primary biliary cirrhosis with Sjögren's syndrome. Mod Rheumatol 14: 70-72
37. Ramos-Casals M et al. (2006) Atypical autoantibodies in patients with primary Sjögren syndrome: Clinical characteristics and follow-up of 82 cases. Semin Arthritis Rheum 35: 312-321
38. Fox RI et al. (2001) Use of muscarinic agonists in the treatment of Sjögren's syndrome. Clin Immunol 101: 249-263
39. null mice reveals a role for autoantibodies in the loss of secretory function of exocrine tissues in Sjögren's syndrome. Proc Natl Acad Sci USA 95: 7538-7543
40. Bacman S et al. (1998) Autoantibodies against lacrimal gland M3 muscarinic acetylcholine receptors in patients with primary Sjögren's syndrome. Invest Ophthalmol Vis Sci 39: 151-156
41. Humphreys-Beher MG and Peck AB (1999) New concepts for the development of autoimmune exocrinopathy derived from studies with the NOD mouse model. Arch Oral Biol 44 (Suppl 1): S21-S25
42. Gordon TP et al. (2001) Autoantibodies in primary Sjögren's syndrome: New insights into mechanisms of autoantibody diversification and disease pathogenesis. Autoimmunity 34: 123-132
43. Dawson LJ et al. (2006) Antimuscarinic antibodies in primary Sjögren's syndrome reversibly inhibit the mechanism of fluid secretion by human submandibular salivary acinar cells. Arthritis Rheum 54: 1165-1173
44. Kovacs L et al. (2005) Clinical associations of autoantibodies to human muscarinic acetylcholine receptor 3(213-228) in primary Sjögren's syndrome. Rheumatology (Oxford) 44: 1021-1025
45. Naito Y et al. (2005) Muscarinic acetylcholine receptor autoantibodies in patients with Sjögren's syndrome. Ann Rheum Dis 64: 510-511
46. Naito Y et al. (2006) Altered peptide ligands regulate muscarinic acetylcholine receptor reactive T cells of patients with Sjögren's syndrome. Ann Rheum Dis 65: 269-271
47. Rhodus NL and Schuh MJ (1991) Effects of pilocarpine on salivary flow in patients with Sjögren's syndrome. Oral Surg Oral Med Oral Pathol 72: 545-549
48. Vivino FB et al. (1999) Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjögren syndrome: A randomized, placebo-controlled, fixed-dose, multicenter trial. P92-01 Study Group. Arch Intern Med 159: 174-181
49. Van de Merwe JP and Arendsen HJ (2000) Interstitial cystitis: A review of immunological aspects of the aetiology and pathogenesis, with a hypothesis. BJU Int 85: 995-999
50. Haarala M et al. (2000) Lower urinary tract symptoms in patients with Sjögren's syndrome and systemic lupus erythematosus. Int Urogynecol J Pelvic Floor Dysfunct 11: 84-86
51. Leppilahti M et al. (2003) Interstitial cystitis-like urinary symptoms among patients with Sjögren's syndrome: A population-based study in Finland. Am J Med 115: 62-65
52. Dafni UG et al. (1997) Prevalence of Sjögren's syndrome in a closed rural community. Ann Rheum Dis 56: 521-525
53. Thomas E et al. (1998) Sjögren's syndrome: A community-based study of prevalence and impact. Br J Rheumatol 37:1069-1076
54. Van de Merwe JP et al. (1994) Sjögren's syndrome, keratoconjunctivitis sicca and focal lymphocytic sialoadenitis in patients with interstitial cystitis. In Sjögren's Syndrome - State of the Art Proceedings of the Fourth International Symposium, 347-349 (Eds Homma M et al.) Amsterdam: Kugler Publications
55. Vitali C et al. (2002) Classification criteria for Sjögren's syndrome: A revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61: 554-558
56. Tyagi S et al. (2006) Qualitative and quantitative expression profile of muscarinic receptors in human urothelium and detrusor. J Urol 176:1673-1678
57. Harriss DR et al. (1995) Expression of muscahnic M3-receptors coupled to inositol phospholipid hydrolysis in human detrusor cultured smooth muscle cells. J Urol 154:1241-1245
58. Mukerji G et al. (2006) Localization of M2 and M3 muscarinic receptors in human bladder disorders and their clinical correlations. J Urol 176:367-373
59. Mansfield KJ et al. (2005) Muscarinic receptor subtypes in human bladder detrusor and mucosa, studied by radioligand binding and quantitative competitive RT-PCR: Changes in ageing. Br J Pharmacol 144: 1089-1099
60. Hegde SS (2006) Muscarinic receptors in the bladder: From basic research to therapeutics. Br J Pharmacol 147 (Suppl 2): S80-S87
61. Wang F et al. (2004) Passive transfer of Sjögren's syndrome IgG produces the pathophysiology of overactive bladder. Arthritis Rheum 50: 3637-3645
62. Siden A and Lindahl G (1990) Signs of Sjögren's syndrome in a patient with myasthenia gravis. Acta Neurol Scand 81:179-180
63. Hughes BW et al. (2004) Pathophysiology of myasthenia gravis. Semin Neurol 24:21-30
64. Kohn LD and Harii N (2003) Thyrotropin receptor autoantibodies (TSHRAbs): Epitopes, origins and clinical significance. Autoimmunity 36:331-337
65. Bouchelouche K et al. (2006) Human detrusor smooth muscle cells release interleukin-6, interleukin-8, and RANTES in response to proinflammatory cytokines interleukin-1β and tumor necrosis factor-α. Urology 67:214-219
66. Chen MC et al. (2007) RANTES mediates TNF-dependent lamina propria mast cell accumulation and barrier dysfunction in neurogenic cystitis. Am J Physiol Renal Physiol 292: F1372-F1379
67. Sant GR et al. (2007) The mast cell in interstitial cystitis: Role in pathophysiology and pathogenesis. Urology 69 (4 Suppl): 34-40
68. Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725